- Home
- ATXS vs MLP Comparison
ATXS vs MLP Comparison
Compare ATXS & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- MLP
- Stock Information
- Founded
- ATXS 2008
- MLP 1909
- Country
- ATXS United States
- MLP United States
- Employees
- ATXS N/A
- MLP N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- ATXS Health Care
- MLP Finance
- Exchange
- ATXS Nasdaq
- MLP Nasdaq
- Market Cap
- ATXS 401.2M
- MLP 411.7M
- IPO Year
- ATXS 2015
- MLP 1972
- Fundamental
- Price
- ATXS $6.81
- MLP $19.79
- Analyst Decision
- ATXS Strong Buy
- MLP
- Analyst Count
- ATXS 6
- MLP 0
- Target Price
- ATXS $25.67
- MLP N/A
- AVG Volume (30 Days)
- ATXS 244.9K
- MLP 11.3K
- Earning Date
- ATXS 03-03-2025
- MLP 03-27-2025
- Dividend Yield
- ATXS N/A
- MLP N/A
- EPS Growth
- ATXS N/A
- MLP N/A
- EPS
- ATXS N/A
- MLP N/A
- Revenue
- ATXS N/A
- MLP $12,196,000.00
- Revenue This Year
- ATXS N/A
- MLP N/A
- Revenue Next Year
- ATXS N/A
- MLP N/A
- P/E Ratio
- ATXS N/A
- MLP N/A
- Revenue Growth
- ATXS N/A
- MLP 34.84
- 52 Week Low
- ATXS $6.64
- MLP $18.52
- 52 Week High
- ATXS $16.90
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- ATXS 31.94
- MLP 43.33
- Support Level
- ATXS $6.77
- MLP $19.36
- Resistance Level
- ATXS $7.30
- MLP $20.32
- Average True Range (ATR)
- ATXS 0.30
- MLP 0.66
- MACD
- ATXS 0.02
- MLP 0.02
- Stochastic Oscillator
- ATXS 14.66
- MLP 52.21
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.